JPWO2020137880A1 - - Google Patents

Info

Publication number
JPWO2020137880A1
JPWO2020137880A1 JP2020563200A JP2020563200A JPWO2020137880A1 JP WO2020137880 A1 JPWO2020137880 A1 JP WO2020137880A1 JP 2020563200 A JP2020563200 A JP 2020563200A JP 2020563200 A JP2020563200 A JP 2020563200A JP WO2020137880 A1 JPWO2020137880 A1 JP WO2020137880A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020563200A
Other languages
Japanese (ja)
Other versions
JP7390031B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020137880A1 publication Critical patent/JPWO2020137880A1/ja
Application granted granted Critical
Publication of JP7390031B2 publication Critical patent/JP7390031B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020563200A 2018-12-27 2019-12-20 オキシトシン誘導体及びその使用 Active JP7390031B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018246141 2018-12-27
JP2018246141 2018-12-27
PCT/JP2019/050089 WO2020137880A1 (ja) 2018-12-27 2019-12-20 オキシトシン誘導体及びその使用

Publications (2)

Publication Number Publication Date
JPWO2020137880A1 true JPWO2020137880A1 (enrdf_load_stackoverflow) 2020-07-02
JP7390031B2 JP7390031B2 (ja) 2023-12-01

Family

ID=71128657

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020563200A Active JP7390031B2 (ja) 2018-12-27 2019-12-20 オキシトシン誘導体及びその使用

Country Status (2)

Country Link
JP (1) JP7390031B2 (enrdf_load_stackoverflow)
WO (1) WO2020137880A1 (enrdf_load_stackoverflow)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150050A (en) * 1980-03-24 1981-11-20 Ferring Ab Oxitocin derivative
JP2004527496A (ja) * 2001-02-28 2004-09-09 モベルグ、ケルスティン ユブナス 新規物質
JP2011516460A (ja) * 2008-03-31 2011-05-26 フェリング ベスローテン フェンノートシャップ オキシトシン類似体
US20130130985A1 (en) * 2010-04-01 2013-05-23 Paul Alewood Oxytocin peptide analogues
JP2013543492A (ja) * 2010-09-30 2013-12-05 フェリング ベスローテン フェンノートシャップ 医薬組成物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150050A (en) * 1980-03-24 1981-11-20 Ferring Ab Oxitocin derivative
JP2004527496A (ja) * 2001-02-28 2004-09-09 モベルグ、ケルスティン ユブナス 新規物質
JP2011516460A (ja) * 2008-03-31 2011-05-26 フェリング ベスローテン フェンノートシャップ オキシトシン類似体
US20130130985A1 (en) * 2010-04-01 2013-05-23 Paul Alewood Oxytocin peptide analogues
JP2013543492A (ja) * 2010-09-30 2013-12-05 フェリング ベスローテン フェンノートシャップ 医薬組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE JOURNAL OF MEDICINAL CHEMISTRY, vol. 62, JPN6023044134, 21 March 2019 (2019-03-21), pages 3297 - 3310, ISSN: 0005186059 *

Also Published As

Publication number Publication date
JP7390031B2 (ja) 2023-12-01
WO2020137880A1 (ja) 2020-07-02

Similar Documents

Publication Publication Date Title
BR122022006221A2 (enrdf_load_stackoverflow)
BR122022015534A2 (enrdf_load_stackoverflow)
BR122022002102A2 (enrdf_load_stackoverflow)
JPWO2020137880A1 (enrdf_load_stackoverflow)
BR122022005529A2 (enrdf_load_stackoverflow)
BR122022016585A2 (enrdf_load_stackoverflow)
BR212020012832U2 (enrdf_load_stackoverflow)
BR202018071071U8 (enrdf_load_stackoverflow)
BR202018008879U2 (enrdf_load_stackoverflow)
BR202018007669U2 (enrdf_load_stackoverflow)
BR202018006247U2 (enrdf_load_stackoverflow)
BR202018004136U2 (enrdf_load_stackoverflow)
BR202018002487U2 (enrdf_load_stackoverflow)
BR202018002069U2 (enrdf_load_stackoverflow)
CN304442171S (enrdf_load_stackoverflow)
CN304201967S8 (enrdf_load_stackoverflow)
CN304435808S (enrdf_load_stackoverflow)
CN304434163S (enrdf_load_stackoverflow)
CN304434161S (enrdf_load_stackoverflow)
CN304434154S (enrdf_load_stackoverflow)
CN304434153S (enrdf_load_stackoverflow)
CN304434112S (enrdf_load_stackoverflow)
CN304434110S (enrdf_load_stackoverflow)
CN304434101S (enrdf_load_stackoverflow)
CN304434040S (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A5211

Effective date: 20210623

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210714

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221220

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20221220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20221220

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231031

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231113

R150 Certificate of patent or registration of utility model

Ref document number: 7390031

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150